Daewon Pharmaceutical Revenue

In the year 2024, Daewon Pharmaceutical had annual revenue of 598.16B KRW with 13.51% growth.

Revenue

598.16B

Revenue Growth

+13.51%

P/S Ratio

0.48

Revenue / Employee

474.73M

Employees

1,260

Market Cap

286.57B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	598.16B	71.21B	13.51%
Dec 31, 2023	526.95B	48.07B	10.04%
Dec 31, 2022	478.88B	124.71B	35.21%
Dec 31, 2021	354.18B	45.68B	14.81%
Dec 31, 2020	308.50B	-9.33B	-2.93%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	68.13B
Peptron	3.15B
LigaChem Biosciences	125.90B

Revenue Rankings